Later, Liu et al. (83) reported that FTO is negatively regulated by the deacetylase SIRT1 via RANBP2-mediated SUMOylation; its downregulation reduces the expression of its target gene guanine nucleotide-binding protein G(O) subunit alpha (GNAO1), thereby promoting the progression of liver cancer. This evidence concerns the gene FTO and liver cancer.